Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ZYPREXA INTRAMUSCULAR ELI LILLY CANADA INC Actual shortage 10MG Updated Report 2022-06-25 162425
MIOCHOL-E BAUSCH & LOMB INC Actual shortage 20MG Updated Report 2022-06-25 158249
BENAZEPRIL AA PHARMA INC Actual shortage 5MG Updated Report 2022-06-25 162443
APO-OXYCODONE/ACET APOTEX INC Actual shortage 325MG 5MG Updated Report 2022-06-24 162478
APO-NAPRO-NA APOTEX INC Actual shortage 275MG Updated Report 2022-06-24 162077
APO-MOXIFLOXACIN APOTEX INC Actual shortage 400MG Updated Report 2022-06-24 162094
APO-SAXAGLIPTIN APOTEX INC Actual shortage 2.5MG Updated Report 2022-06-24 152773
APO-SAXAGLIPTIN APOTEX INC Actual shortage 5MG Updated Report 2022-06-24 154208
APO-GEFITINIB APOTEX INC Resolved 250MG Updated Report 2022-06-24 158819
STIEVA-A GLAXOSMITHKLINE INC Actual shortage 0.01% New Report 2022-06-24 163422

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
VENTOLIN NEBULES P.F. - 2.5MG/2.5ML GLAXOSMITHKLINE INC Discontinued 2.5MG Updated Report 2022-06-24 130633
SANDOZ ESOMEPRAZOLE SANDOZ CANADA INCORPORATED Discontinued 40MG New Report 2022-06-23 163310
VIBERZI ALLERGAN INC Reversed 100MG Updated Report 2022-06-22 157159
PROPYL-THYRACIL PALADIN LABS INC. Discontinued 50MG Updated Report 2022-06-21 101076
PROPYL-THYRACIL PALADIN LABS INC. Discontinued 100MG Updated Report 2022-06-21 107174